UBS Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $926K | Sell |
408,035
-338,753
| -45% | -$769K | ﹤0.01% | 4408 |
|
2025
Q1 | $475K | Buy |
746,788
+238,232
| +47% | +$152K | ﹤0.01% | 4710 |
|
2024
Q4 | $524K | Buy |
508,556
+439,421
| +636% | +$453K | ﹤0.01% | 4661 |
|
2024
Q3 | $81.6K | Sell |
69,135
-1,233
| -2% | -$1.46K | ﹤0.01% | 5301 |
|
2024
Q2 | $85.8K | Buy |
70,368
+49,875
| +243% | +$60.8K | ﹤0.01% | 5159 |
|
2024
Q1 | $44.7K | Buy |
20,493
+446
| +2% | +$972 | ﹤0.01% | 5396 |
|
2023
Q4 | $31.1K | Buy |
20,047
+1,344
| +7% | +$2.08K | ﹤0.01% | 5621 |
|
2023
Q3 | $24.1K | Sell |
18,703
-2,737
| -13% | -$3.53K | ﹤0.01% | 5565 |
|
2023
Q2 | $36.9K | Sell |
21,440
-5,353
| -20% | -$9.21K | ﹤0.01% | 5561 |
|
2023
Q1 | $40.5K | Sell |
26,793
-19,007
| -42% | -$28.7K | ﹤0.01% | 5515 |
|
2022
Q4 | $73.3K | Buy |
45,800
+28,007
| +157% | +$44.8K | ﹤0.01% | 5255 |
|
2022
Q3 | $26K | Buy |
17,793
+13,585
| +323% | +$19.9K | ﹤0.01% | 5952 |
|
2022
Q2 | $8K | Buy |
4,208
+2,500
| +146% | +$4.75K | ﹤0.01% | 7255 |
|
2022
Q1 | $5K | Sell |
1,708
-138,773
| -99% | -$406K | ﹤0.01% | 8049 |
|
2021
Q4 | $608K | Sell |
140,481
-16,692
| -11% | -$72.2K | ﹤0.01% | 3835 |
|
2021
Q3 | $800K | Buy |
157,173
+131,922
| +522% | +$671K | ﹤0.01% | 3410 |
|
2021
Q2 | $160K | Sell |
25,251
-56,209
| -69% | -$356K | ﹤0.01% | 4495 |
|
2021
Q1 | $630K | Buy |
81,460
+80,052
| +5,686% | +$619K | ﹤0.01% | 3762 |
|
2020
Q4 | $9K | Buy |
1,408
+208
| +17% | +$1.33K | ﹤0.01% | 6527 |
|
2020
Q3 | $8K | Hold |
1,200
| – | – | ﹤0.01% | 6123 |
|
2020
Q2 | $10K | Sell |
1,200
-21,457
| -95% | -$179K | ﹤0.01% | 6149 |
|
2020
Q1 | $174K | Sell |
22,657
-34,542
| -60% | -$265K | ﹤0.01% | 3990 |
|
2019
Q4 | $475K | Sell |
57,199
-32,032
| -36% | -$266K | ﹤0.01% | 3935 |
|
2019
Q3 | $658K | Buy |
89,231
+65,403
| +274% | +$482K | ﹤0.01% | 3510 |
|
2019
Q2 | $267K | Buy |
23,828
+11,790
| +98% | +$132K | ﹤0.01% | 3929 |
|
2019
Q1 | $130K | Sell |
12,038
-75,073
| -86% | -$811K | ﹤0.01% | 4118 |
|
2018
Q4 | $1.32M | Buy |
87,111
+75,258
| +635% | +$1.14M | ﹤0.01% | 2773 |
|
2018
Q3 | $219K | Buy |
11,853
+9,544
| +413% | +$176K | ﹤0.01% | 4172 |
|
2018
Q2 | $53K | Sell |
2,309
-43,628
| -95% | -$1M | ﹤0.01% | 5026 |
|
2018
Q1 | $1.31M | Buy |
45,937
+34,767
| +311% | +$989K | ﹤0.01% | 2844 |
|
2017
Q4 | $236K | Sell |
11,170
-4,149
| -27% | -$87.7K | ﹤0.01% | 3911 |
|
2017
Q3 | $278K | Buy |
15,319
+12,800
| +508% | +$232K | ﹤0.01% | 3818 |
|
2017
Q2 | $39K | Sell |
2,519
-525
| -17% | -$8.13K | ﹤0.01% | 4907 |
|
2017
Q1 | $53K | Sell |
3,044
-1,018
| -25% | -$17.7K | ﹤0.01% | 4582 |
|
2016
Q4 | $45K | Buy |
4,062
+3,186
| +364% | +$35.3K | ﹤0.01% | 4986 |
|
2016
Q3 | $14K | Buy |
+876
| New | +$14K | ﹤0.01% | 5644 |
|
2016
Q2 | – | Sell |
-402
| Closed | -$5K | – | 6794 |
|
2016
Q1 | $5K | Sell |
402
-262
| -39% | -$3.26K | ﹤0.01% | 6132 |
|
2015
Q4 | $14K | Buy |
+664
| New | +$14K | ﹤0.01% | 5799 |
|